Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for disorders affecting children, progress and potential.

Donald S Anson1, Janice M Fletcher

  • 1Department of Genetic Medicine, Children, Youth and Women's Health Service, University of South Australia, Adelaide, South Australia, Australia. donald.anson@adelaide.edu.au

Journal of Paediatrics and Child Health
|May 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extending the new era of genomic testing into pregnancy management: A proposed model for Australian prenatal services.

The Australian & New Zealand journal of obstetrics & gynaecology·2024
Same author

Isolated autism is not an indication for Smith-Lemli-Opitz syndrome biochemical testing.

Journal of paediatrics and child health·2021
Same author

Fatal perinatal mitochondrial cardiac failure caused by recurrent <i>de novo</i> duplications in the <i>ATAD3</i> locus.

Med (New York, N.Y.)·2021
Same author

Mono-symptomatic Fabry disease in a population with mild-to-moderate left ventricular hypertrophy.

Molecular genetics and metabolism reports·2020
Same author

Chondroitin sulfate disaccharide is a specific and sensitive biomarker for mucopolysaccharidosis type IVA.

JIMD reports·2020
Same author

Identification and targeted management of a neurodegenerative disorder caused by biallelic mutations in SLC5A6.

NPJ genomic medicine·2019

Gene therapy for inherited pediatric diseases shows promise despite past challenges. Recent advancements in gene delivery technology and understanding biological complexities are paving the way for clinical success.

Area of Science:

  • * Medical Genetics
  • * Molecular Biology
  • * Biotechnology

Background:

  • * Gene therapy has been explored for inherited pediatric diseases for over 20 years.
  • * Clinical impact has been limited due to technological and biological complexity challenges.
  • * Recent progress suggests these hurdles are being overcome.

Purpose of the Study:

  • * To review gene delivery technologies and strategies for gene therapy.
  • * To identify potential target diseases for gene therapy.
  • * To highlight specific diseases with active gene therapy development.

Main Methods:

  • * Literature review of gene delivery technologies.
  • * Analysis of gene therapy strategies.
  • * Case studies of diseases under active gene therapy development.

Related Experiment Videos

Main Results:

  • * Gene delivery technologies and strategies are advancing.
  • * Several inherited pediatric diseases are identified as potential targets.
  • * Specific examples of active gene therapy development are presented.

Conclusions:

  • * Gene therapy is poised to significantly impact the treatment of certain inherited pediatric disorders.
  • * Overcoming technological and biological challenges is key to clinical success.
  • * Continued research and development are crucial for realizing gene therapy's potential.